| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anne Munch Christensen, Sofie Faaborg-Andersen, Flemming Ingerslev, Anders Bau. Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans. Environmental toxicology and chemistry. vol 26. issue 1. 2007-02-22. PMID:17269464. |
selective serotonin reuptake inhibitors (ssris) are used as antidepressant medications, primarily in the treatment of clinical depression. |
2007-02-22 |
2023-08-12 |
Not clear |
| J Brent Richards, Alexandra Papaioannou, Jonathan D Adachi, Lawrence Joseph, Heather E Whitson, Jerilynn C Prior, David Goltzma. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Archives of internal medicine. vol 167. issue 2. 2007-02-16. PMID:17242321. |
selective serotonin reuptake inhibitors (ssris) are frequently used in the treatment of depression in this population, and the association between daily ssri use and fragility fractures is unclear. |
2007-02-16 |
2023-08-12 |
Not clear |
| Jorge A Cervilla, Margarita Rivera, Esther Molina, Francisco Torres-González, Juan A Bellón, Berta Moreno, Juan de Dios Luna, José A Lorente, Yolanda de Diego-Otero, Michael King, Irwin Nazareth, Blanca Gutiérre. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 141B. issue 8. 2007-02-13. PMID:17063469. |
the 5-httlpr s/s genotype at the serotonin transporter gene (slc6a4) increases the risk for depression in a large cohort of primary care attendees: the predict-gene study. |
2007-02-13 |
2023-08-12 |
human |
| Jorge A Cervilla, Margarita Rivera, Esther Molina, Francisco Torres-González, Juan A Bellón, Berta Moreno, Juan de Dios Luna, José A Lorente, Yolanda de Diego-Otero, Michael King, Irwin Nazareth, Blanca Gutiérre. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 141B. issue 8. 2007-02-13. PMID:17063469. |
previous reports and meta-analyses have yielded inconclusive results as to whether the s/s genotype at the 5-httlpr serotonin transporter polymorphism confers increased risk for depression. |
2007-02-13 |
2023-08-12 |
human |
| Wiesław Jerzy Cubała, Jerzy Landowsk. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression]. Psychiatria polska. vol 40. issue 3. 2007-02-08. PMID:17037809. |
depression is associated with the dysfunction in the serotoninergic (5-ht, 5-hydroxytryptamine) transmission and dysregulation of the limbic-hypothalamic-pituitary-adrenal axis (lhpa axis). |
2007-02-08 |
2023-08-12 |
Not clear |
| David Cohe. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned? Psychotherapy and psychosomatics. vol 76. issue 1. 2007-02-06. PMID:17170559. |
should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned? |
2007-02-06 |
2023-08-12 |
Not clear |
| David Cohe. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned? Psychotherapy and psychosomatics. vol 76. issue 1. 2007-02-06. PMID:17170559. |
european and us pharmaceutical agencies have recently warned against the use of selective serotonin reuptake inhibitors (ssris) in child and adolescent depression. |
2007-02-06 |
2023-08-12 |
Not clear |
| P Nowak, G Szczerbak, I Biedka, M Drosik, R M Kostrzewa, R Bru. Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. vol 57. issue 4. 2007-02-06. PMID:17229983. |
as 5-ht(2a/2c) receptor-mediated transmission might prove usefulness not only in addressing motor complications of pd patients (dyskinesia) but also in addressing non-motor problems such depression and/or l-dopa evoked psychosis, the findings from the current study showed that the use of 5-ht(2a/2c) receptor antagonists in parkinson's disease does not impend the neostriatal neuropil to be damaged by these drugs. |
2007-02-06 |
2023-08-12 |
human |
| Roja Rahimi, Shekoufeh Nikfar, Mohammad Abdollah. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials. Reproductive toxicology (Elmsford, N.Y.). vol 22. issue 4. 2007-02-05. PMID:16720091. |
serotonin reuptake inhibitors (sris) are extensively used in management of clinical depression. |
2007-02-05 |
2023-08-12 |
Not clear |
| Ana M Catafau, Victor Perez, Pedro Plaza, Juan-Carlos Pascual, Santiago Bullich, Marina Suarez, Maria M Penengo, Iluminada Corripio, Dolors Puigdemont, Monica Danus, Javier Perich, Enric Alvare. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study. Psychopharmacology. vol 189. issue 2. 2007-02-05. PMID:17033844. |
serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123i-adam spect study. |
2007-02-05 |
2023-08-12 |
Not clear |
| C Vakalopoulo. Neurocognitive deficits in major depression and a new theory of ADHD: a model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals. Medical hypotheses. vol 68. issue 1. 2007-01-30. PMID:16997497. |
the model also predicts memory impairment in major depression by proposing that low serotonin levels in the neocortex is linked to focal hippocampal dysfunction. |
2007-01-30 |
2023-08-12 |
Not clear |
| Numan Konuk, Nuray Atasoy, Levent Atik, Omer Aka. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors. Advances in therapy. vol 23. issue 4. 2007-01-29. PMID:17050507. |
open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors. |
2007-01-29 |
2023-08-12 |
human |
| Roland W Freudenmann, Carlos Schönfeldt-Lecuona, Manfred Spitzer, Leopold Hermle, Georg Grö. Electroconvulsive therapy in the treatment of depression in a former ecstasy user. Journal of psychopharmacology (Oxford, England). vol 20. issue 6. 2007-01-26. PMID:16891342. |
depression in former ecstasy users may not respond to selective serotonin reuptake inhibitors (ssris) possibly due to damaged serotonergic synapses following long-term heavy ecstasy use. |
2007-01-26 |
2023-08-12 |
Not clear |
| Daniel Cukor, Rolf A Peterson, Scott D Cohen, Paul L Kimme. Depression in end-stage renal disease hemodialysis patients. Nature clinical practice. Nephrology. vol 2. issue 12. 2007-01-25. PMID:17124525. |
limited evidence regarding the safety and efficacy of treatment of hemodialysis patients with selective serotonin reuptake inhibitors is available, and cognitive behavioral therapy holds promise as an intervention for depression in this complex medical population. |
2007-01-25 |
2023-08-12 |
Not clear |
| B G Oertel, A Schneider, M Rohrbacher, H Schmidt, I Tegeder, G Geisslinger, J Lötsc. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans. Clinical pharmacology and therapeutics. vol 81. issue 1. 2007-01-17. PMID:17186000. |
based on experiments in rats, serotonin receptor 5-hydroxytryptamine (5-ht)(1a) agonists have been proposed as a potential therapeutic strategy for the selective treatment of opioid-induced respiratory depression. |
2007-01-17 |
2023-08-12 |
human |
| B G Oertel, A Schneider, M Rohrbacher, H Schmidt, I Tegeder, G Geisslinger, J Lötsc. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans. Clinical pharmacology and therapeutics. vol 81. issue 1. 2007-01-17. PMID:17186000. |
oral co-administration of a high dose of the clinically available 5-ht(1a) agonist buspirone cannot be advised as a remedy for opioid-induced respiratory depression. |
2007-01-17 |
2023-08-12 |
human |
| Sheila A Doggrel. After the failure of citalopram for depression, what next? Expert opinion on pharmacotherapy. vol 7. issue 11. 2007-01-16. PMID:16859434. |
the choice of treatment after failure of selective serotonin re-uptake inhibitors in the treatment of depression largely depends on the preferences of the physician. |
2007-01-16 |
2023-08-12 |
human |
| Soraya F Habr-Alencar, Renata G Dias, Elizabeth Teodorov, Maria Martha Bernard. The effect of hetero- and homosexual experience and long-term treatment with fluoxetine on homosexual behavior in male rats. Psychopharmacology. vol 189. issue 3. 2007-01-16. PMID:17016704. |
the selective serotonin reuptake inhibitors have become the most frequently prescribed drugs for the treatment of depression. |
2007-01-16 |
2023-08-12 |
rat |
| Somaia Mohamed, Katerine Osatuke, Muhammed Aslam, John Kascko. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial. The American journal of geriatric pharmacotherapy. vol 4. issue 3. 2007-01-12. PMID:17062320. |
selective serotonin reuptake inhibitors have been found to be effective in treating both depression and anxiety; however, pharmacodynamic and pharmacokinetic changes associated with aging warrant special attention in medication trials in older patients. |
2007-01-12 |
2023-08-12 |
Not clear |
| Robert K McNamara, Susan E Carlso. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins, leukotrienes, and essential fatty acids. vol 75. issue 4-5. 2007-01-11. PMID:16949263. |
animal studies have demonstrated that reductions in perinatal brain dha accrual are associated with deficits in neuronal arborization, multiple indices of synaptic pathology including deficits in serotonin and mesocorticolimbic dopamine neurotransmission, neurocognitive deficits, and elevated behavioral indices of anxiety, aggression, and depression. |
2007-01-11 |
2023-08-12 |
Not clear |